Information Provided By:
Fly News Breaks for December 6, 2019
Dec 6, 2019 | 04:58 EDT
BMO Capital analyst Matt Borsch initiated coverage of Amedisys with a Market Perform rating and $170 price target. The analyst says a "high" valuation and structural reimbursement/regulatory risks offset his positive view of the company's outlook.
News For AMED From the Last 2 Days
There are no results for your query AMED